Prof. Dr. Keiji Terao, President and CEOCycloChem Bio has developed cyclodextrin-based (CD) inclusion technologies, using α-, β- and γ- CDs to support consistent ingredient performance. The naturally derived cyclic sugar molecules are produced from maize starch, and are characterized by a unique, ring-shaped structure containing nano-sized cavities capable of encapsulating other molecules. These cavities enclose delicate functional ingredients and prevent them from degrading.
The technology significantly improves stability, extends shelf life and enhances formulation flexibility without altering the original biological properties of the encapsulated ingredient. It also improves the water dispersibility and bioavailability of compounds that otherwise exhibit poor absorption. Even while functioning as an inclusion complex, α-CD also serves as a functional dietary fiber, adding nutritional value.
CycloChem Bio has also developed Fresh Oligo Powder Technology, which applies the same scientific principles to convert natural materials into powders that retain their biological activity and freshness. The combination expands formulation possibilities for manufacturers serving the nutritional, beauty and functional food markets.
“Understanding molecular structure allows us to unlock biological functions that conventional ingredient development often overlooks," says Prof. Dr. Keiji Terao, president and CEO.
Dr. Terao is an organic chemist whose distinguished career has been dedicated to CD research and functional ingredient chemistry. Drawing on decades of research, scientific publications and human clinical studies, he evaluates every functional ingredient from the perspective of precise molecular structure. That chemistry-first mindset guides CycloChem Bio to identify how molecules behave inside the body and translate that knowledge into commercially viable ingredient solutions.
Engineering Function at the Molecular Level
Central to this approach is its ability to match different CDs with different biological challenges. α-CD stands out as a water-soluble dietary fiber with applications spanning gut health, metabolic wellness and functional nutrition. Many dietary fibers and prebiotics available today consist of mixtures of compounds that do not get completely digested. But α-CD as a single molecule possesses a precisely defined molecular structure that makes it completely indigestible by human digestive enzymes. The entire amount reaches the large intestine intact, where it can be efficiently utilized by specific beneficial gut microorganisms that are useful for beauty and wellness.
“I believe 100 percent delivery and utilization is what truly defines the value of a real prebiotic,” says Dr. Terao.
I’m not just trying to sell my company’s products. As a scientist, I want to make evidence-based truths common sense.
CycloChem Bio has also explored α-CD's potential to address lifestyle-related health concerns. Research demonstrated that α-CD can help suppress post-meal blood glucose spikes. It also reduces small dense LDL, the cholesterol particle increasingly associated with the development of arteriosclerosis. By targeting this specific form of LDL instead of lipoprotein cholesterol alone, it supports a more precise approach to cardiovascular health.
CycloChem Bio supplies α-CD for nutritional supplements, functional foods and metabolic wellness formulations designed to support gut health, healthy aging and long-term lifestyle management.
β-CD, known for its exceptional molecular stability, is particularly effective at encapsulating cholesterol and supports specialized inclusion applications where stable molecular complexation is required.
γ-CD serves as an advanced carrier system for highly fat-soluble compounds that usually exhibit poor absorption. It prevents those molecules from combining. This allows bile acids to form micelles that separate fat-soluble substances molecule by molecule more efficiently and significantly improves intestinal absorption.
Extending Nature's Functionality
CycloChem Bio's expertise in CD inclusion extends into the preservation of natural ingredients. Its Fresh Oligo Powder Technology turns functional ingredients found in fresh vegetables and fruits into commercially stable powders using α-CD during the powdering process.
Traditional drying methods expose ingredients to high temperatures, accelerating oxidation. This degrades enzymes and reduces the activity of functional compounds.
Encapsulation using Fresh Oligo Powder Technology shields compounds from heat, light and oxygen, allowing them to retain the stability required for commercial manufacturing and long-term storage. The finished powders preserve the functionality, aroma and freshness of the raw materials.
The technology has shown promising results across a range of natural materials. Delicate enzymes such as actinidin, derived from kiwi fruit, retain nearly full activity after long-term storage. Volatile compounds like isothiocyanates from radish remain significantly more stable than those in conventional formulations. Similar approaches have been applied to ingredients derived from olives, watermelon and other agricultural resources.
The technology also helps develop new ingredient systems where existing formulations show limitations. For example, in South Korea, α-CD has attracted significant attention as a slimming ingredient, creating a demand for several hundred tons annually. But research indicates that α-CD's benefits are most effective among individuals who are obese with a high BMI seeking to lose weight, but they don't work for those who are just a bit overweight. Building on these findings, CycloChem Bio has developed radish fresh powder, an α-CD inclusion complex that has demonstrated potential weight loss support for those with moderately elevated BMI.
The same platform supports a broader sustainability objective. CycloChem Bio collaborates with agricultural producers to transform non-standard or underutilized crops into premium functional ingredients. Converting surplus agricultural materials into stable, value-added powders suitable for domestic and international markets contributes to resource efficiency and creates new commercial opportunities for regional agriculture.
Supporting High-Performance Human Chemicals
CycloChem Bio's research goes beyond plant-derived functional ingredients to compounds naturally produced within the human body. Dr. Terao refers to these compounds as ‘hitochemicals,’ a term derived from the Japanese word for human. These naturally occurring molecules play essential roles in maintaining health. Production of these compounds gradually declines after the age of 20. CycloChem Bio sees significant potential in developing technologies that help restore their availability and effectiveness.
Coenzyme Q10 is one of the three major hitochemicals identified by Dr. Terao because of its essential role in mitochondrial energy production. Acting as a coenzyme, it supports the production of ATP, the energy source required by every cell in the body. It also functions as a powerful antioxidant that helps neutralize reactive oxygen species generated during energy metabolism.
-
Understanding molecular structure allows us to unlock biological functions that conventional ingredient development often overlooks.
Its relevance for individuals taking statins for treating lipid disorders is important. Although statins effectively reduce cholesterol synthesis, they also inhibit the body's natural production of CoQ10 because both are produced through the same metabolic pathway. Reduced levels are typically associated with fatigue, poor circulation and diminished cellular function, making supplementation vital.
The second major hitochemical, R-α-lipoic acid, plays an indispensable role in converting glucose into cellular energy by supporting key enzymatic reactions within the mitochondria. R-α-lipoic acid is also recognized for its exceptional antioxidant capacity, helping neutralize reactive oxygen species while regenerating depleted antioxidants such as Coenzyme Q10, vitamins C and E and glutathione. It also plays a role in suppressing glycation, a process where excess sugars damage proteins and accelerate aging.
Since CoQ10 is fat-soluble, its bioavailability is extremely low. However, it can be significantly enhanced by solubilizing in digestive fluids through encapsulation with γ-CD. The bioavailability of R-α-lipoic acid is also low because it is unstable in stomach acid. So, it was found that stabilizing it through γCD encapsulation improves its bioavailability.
L-carnitine, the third major hitochemical, transports fatty acids into the mitochondria, where they are converted into energy, making it an important component for fat metabolism, muscle function and physical performance. While L-carnitine is readily absorbed by the body, its hygroscopic nature makes it difficult to formulate as a stable commercial ingredient. Encapsulating L-carnitine with α-CD creates a stable powder that preserves its functionality while improving handling and formulation.
Championing Science-Backed Nutrition
Alongside product development, CycloChem Bio is committed to narrowing the gap between emerging scientific evidence and its adoption in healthcare and consumer nutrition. It believes that many clinically relevant findings remain underutilized in everyday practice, limiting opportunities to improve preventive health and lifestyle management. The company remains dedicated to advancing scientific understanding of CD through ongoing collaborations with universities, healthcare researchers and academic organizations.
“I’m not just trying to sell my company’s products, says Dr. Terao. As a scientist, I want to make evidence-based truths common sense.”
As consumer expectations continue shifting toward evidence-based nutrition, personalized wellness and naturally derived functional ingredients, technologies that preserve ingredient efficacy will play an increasingly important role. CycloChem Bio's expertise in cyclodextrin chemistry positions it to address these evolving demands.
Deep Dive
Cycloencapsulation Technology for Functional Ingredient Stability
Heat exposure during powder processing can undermine the value of a functional ingredient well before procurement has a finished product to assess. Volatile plant compounds may lose aroma or activity, while poorly soluble nutrients can remain difficult to absorb even when they look good on a label. Dietary fibers positioned as prebiotic materials may also reach the gut in inconsistent fractions. That leaves formulators trying to support claims that ultimately depend on molecular behavior the customer cannot see.
Choosing cycloencapsulation technology involves more than selecting a coating method. What matters is how well the technology controls what survives processing and what becomes available after consumption. Much of that depends on choosing the right molecule.
Cyclodextrins are not interchangeable, and selecting the wrong host can result in a formulation that looks right but fails to deliver its intended biological or sensory function. Technical evaluation should therefore establish whether the encapsulating molecule is suited to both the ingredient and the dosage form, rather than relying on a broad claim of compatibility.
Weaknesses in development often show up during shelf-life testing. Natural extracts and delicate enzymes may perform well during early testing but begin to deteriorate during drying or storage. Conventional powdering can make an ingredient easier to handle while compromising the very substance that gives the formulation its value. This makes it important to understand how the supplier protects active ingredients from heat and oxygen, how long their activity holds under normal storage conditions and whether the finished powder can run through existing production processes without requiring special handling that makes commercial scale impractical.
"Its work spans CD and CD inclusion body development, with alpha-cyclodextrin used as a defined dietary fiber and gamma-cyclodextrin applied to improve uptake of poorly soluble compounds such as CoQ10."
Absorption brings a different challenge. Fat-soluble nutrients often disperse poorly in aqueous environments, so having the right ingredient on the label does not necessarily mean the body receives the expected amount. Cyclodextrin complexes can help close that gap when their inclusion behavior supports release and micellar dispersion in the digestive tract. But the supporting evidence needs to relate directly to the formulation rather than relying on findings from unrelated chemistry. The important question is whether the molecular structure translates into measurable performance in the intended application.
Claims also deserve close attention. Consumers of functional foods and supplements respond to straightforward claims, while regulators and technical reviewers require evidence to support them. Blood glucose response and lipid markers, for example, call for different types of substantiation. Gut microbiome benefits bring another consideration because the ingredient has to reach the large intestine; simply naming it in the formulation is not enough. Vendors that distinguish promising research from evidence strong enough to support a claim can save brand owners trouble later. They should also understand when an ingredient is suited to a narrow population and when another complex could open the door to broader use, while recognizing trends that may disappear before buyers invest too heavily in them.
CycloChem Bio brings this molecule-level approach to cycloencapsulation rather than treating encapsulation as a generic process. Its work spans CD and CD inclusion body development, with alpha-cyclodextrin used as a defined dietary fiber and gamma-cyclodextrin applied to improve uptake of poorly soluble compounds such as CoQ10. Its Fresh Oligo Powder approach addresses natural materials whose enzymes or volatile components need to remain active after powdering. For teams evaluating stability evidence and application fit, CycloChem Bio provides a disciplined path from an ingredient concept to a functional material.
...Read more
